Your session is about to expire
← Back to Search
Prebiotic
Single Arm for Parkinson's Disease
N/A
Waitlist Available
Led By Deborah A Hall, MD PhD
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 days
Awards & highlights
Study Summary
Prebiotics in the Parkinson's Disease Microbiome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Tolerability of prebiotic bar after 10 days in PD participants
Secondary outcome measures
Safety of prebiotic bar during 10 days in Parkinson's disease participants
Other outcome measures
Changes in PD related gastrointestinal symptoms
Changes in brain health
Intestines
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Open-label consumption of prebiotic bar(s); 1 bar for 3 days; followed by 2 bars for 7 days
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
163,481 Total Patients Enrolled
Deborah A Hall, MD PhDPrincipal InvestigatorRush University Medical Center
1 Previous Clinical Trials
10 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger